Today, cancer is no longer on the list of incurable diseases, thanks to medical developments in the last few decades. Yet, it is hard to ignore the fact that cancer does alter the lives of patients. We know of many adults that have undergone not just physical but an emotional overhaul during their cancer journey - some of them returning to life with an altered perspective and unending empathy for people around them after having been through the trials and trauma of chemotherapy and radiation.
For children, it might be a totally different story. For many of them, the effects of cancer treatment do not begin until later in life resulting in other health concerns. In fact, studying these late effects is the research focus of many medical researchers in the field of pediatric cancer. Many of these effects are the result of how chemotherapy works - in order to kills the cancerous cells, it destroys a good number of healthy cells as collateral damage.
I recently spoke with Dr. Ramesh Rengan, medical director of Seattle Cancer Care Alliance (SCCA) Proton Therapy Center in Seattle, Washington, and a long-term researcher in the field of novel radiation approaches with immune therapies in the treatment of cancer. Dr. Rengan is an active voice for proton therapy emerging as an increasingly effective and less harmful way to treat specific types of cancers, particularly pediatric cancers and those that occur close to vital organs.
Here are a few excerpts from our interview:
The SCCA Proton center works on an alternative treatment method for cancer. Can you tell us more about it?
At the SCCA Proton Therapy Center, we use highly targeted proton beam radiation to treat cancer. By precisely focusing on the tumor, proton therapy minimizes radiation exposure to surrounding healthy tissue, thereby reducing the risk of short- and long-term radiation-related side effects. Our center is currently the only proton therapy center in the Pacific Northwest.
How does proton therapy work?
The fundamental concept underlying all cancer treatment is to deliver a lethally effective treatment to the cancer and only the cancer, be it chemotherapy, surgery or radiation. The challenge for the oncologist is to design a way to deliver this treatment with specificity to the tumor while minimizing the damage to the surrounding organs. What really dictates the long-term clinical outcome for the patient is not just the number of cancer cells that we kill but the balance between that and the number of healthy cells that are injured in the course of treatment.
Standard radiation uses X-ray beams that enter and pass through the patient to the tumor and exit the other side. However, because X-rays penetrate so well, all tissue that lies in front of and beyond the tumor is exposed to radiation, which can be potentially harmful to the patient.
Protons, due to their mass, stop within the patient and do not continue to pass through the body. We can therefore calibrate the proton beam to stop within the tumor itself. Additionally, due to their positive charge, protons deposit most of their radiation at the point where they stop, rather than near the point of entry into the patient as X-rays do. As a result of these properties, protons concentrate the radiation dose delivery to the tumor itself. This more targeted form of radiation is especially useful for pediatric cancers, where any excess radiation exposure to healthy, developing organs can be potentially harmful.
What are the benefits of proton therapy over other types of cancer treatments?
Protons allow radiation to be delivered to the tumor while significantly minimizing collateral radiation exposure to surrounding healthy tissue. That benefit pays dividends in the near term because it reduces exposure, and it drives additional future benefits as patients continue with their lives after treatment, such as fewer secondary cancers. The precision that protons allow is particularly beneficial for patients whose tumors are near critical organs or structures, such as the brain, bladder, rectum, heart or spinal cord; patients whose cancers have recurred after initial radiation treatment; and patients whose organs are particularly sensitive to radiation exposure, such as children and adults with certain genetic syndromes.
For what kind of cancers is the proton therapy most effective ?
Although protons can be used to treat most cancers that require radiation, this treatment has been best established for tumors that lie in close proximity to radiosensitive vital organs, such as central nervous system tumors and eye tumors. For pediatric patients, protons have become an indispensable tool, as children are particularly vulnerable to the negative effects of radiation. Therefore, proton treatment for many pediatric tumors is a well-established standard of care, despite the limited access to proton therapy centers worldwide. Today, we also treat tumors in the head and neck, lung, breast, esophagus and gastrointestinal system, as these tumors are often situated next to radiosensitive vital organs. As such, the role of protons is being actively investigated in ongoing clinical trials in these disease locations.
Are protons a stand-alone treatment, or is it best used in conjunction with other therapies?
Proton therapy can often be used in combination with chemotherapy and surgery, similar to standard radiation treatment.
How is proton therapy improving?
Access to clinics, lowered cost, optimized technology to treat a broader range of tumors and use of a combination of approaches to treatment are the biggest recent leaps we have made with proton treatment.
Its important to understand that protons initially were postulated in the treatment of cancer in a paper published in 1946. Protons are not new as a modality, having been around since the 1950s. It has taken a long time for the technology to become relatively cost-efficient and be feasibly delivered in a hospital-based or stand-alone outpatient clinical setting such as the Seattle Cancer Care Alliance Proton Therapy Center.
Growth has been deliberate and incremental: the first hospital-based proton center opened in the 90s. Today there are 20 proton centers in North America, but the real promise of proton treatment is being realized now. During the next 10 years, we expect to see that number triple or quadruple, as the cost of building a center has been rapidly decreasing while proton beam technology has been simultaneously improving.
Are protons the best choice for everyone?
Protons are just as effective as X-rays in killing cancer cells but generally require less exposure to surrounding healthy tissues in order to deliver this treatment to the cancer, so they are a potential option whenever radiation is called for in the curative treatment of cancer. However, protons are only a single tool in the ever-increasing arsenal against cancer. As such, protons are the best treatment for some patients, but not for others. The decision regarding whether protons are the right choice for a given patient is made by a proton-experienced radiation oncologist in conjunction with members of the multidisciplinary cancer care team and the patient.
What do you believe are the next big revolutions in cancer treatments?
The big revolution in cancer treatment will come from our increasing ability to deliver effective therapies to the tumor with absolute specificity. For example, that is the founding principle behind cancer immunotherapy, namely, to turn our immune system against the cancer. Similarly, the greater our ability to focus our radiation beam or our scalpels at purely the cancer and minimize the impact to the surrounding organs, the greater the benefit to our patients.
In the past few years we have made fundamental paradigm shifts in the way we treat cancer. Today we attack cancer by exploiting the unique genetic characteristics of the tumor to design drugs that attack the cancer by homing in on their gene signature. Even with these modern advancements, it must be mentioned that cancer is not just treated with one method alone; a combination of weapons is used to effectively cure most cancers. One might say that it takes a village to effectively treat a cancer patient.
Much of the early history of cancer treatment had focused on maximizing the lethality of our weapons against the cancer, either by increasing the radiation or chemotherapy dose or by performing larger and more radical surgery to remove the tumor. We now recognize that the impact of these treatments on healthy tissue can have an even greater negative effect on the clinical outcome than the positive benefit of killing the tumor. In short, we dont need a bigger gun or bomb, but rather a smarter bomb that equally emphasizes supporting the health of the patient and the destruction of the cancer. Protons are ideally suited to this evolution in cancer care.
Devishobhais the founder ofKidskintha,a happy place to jumpstart conversations around family and millennial parenting, living in India. You can find her voiceon the Huffington Post,LifeHack, Parent.co,Addicted2Success, Inc.com, Entrepreneur, Tiny Buddha,SivanaEast and others on a range of topics. You can get yourself equipped for happy parenting with one hack a week for an entire year (each one backed by science).
The Morning Email
Wake up to the day's most important news.
- Retinal Dystrophy Treatment Market Development, Market Trends, Key Driven Factors, Segmentation And Forecast To 2020-2026| GlaxoSmithKline, Applied... - May 24th, 2020
- COVID-19 UPDATE: Precision Medicine Market 2020: Industry Analysis and Detailed Profiles of Top Industry Players are Neon Therapeutics, Moderna, Inc,... - May 24th, 2020
- Precision Cancer Therapies Market Set for Rapid Growth and Trends in 2020 to 2025 |Abbott Laboratories, Bayer HealthCare, GlaxoSmithKline, OncoGenex... - May 16th, 2020
- Why does immune response to coronavirus save some, kill others? - OCRegister - May 16th, 2020
- Global Choroideremia Treatment Market Growth, Outlook, Trend and Forecast by Wize Pharma Inc, Spark Therapeutics, Inc, PIXIUM VISION, Retina Implant... - May 14th, 2020
- Why does immune response to coronavirus save some, kill others? - East Bay Times - May 14th, 2020
- Juvenile Macular Degeneration (Stargardt Disease) Treatment Market Growth and key Industry Players 2021 Analysis and Forecasts to 2026 - Express... - May 14th, 2020
- Size & Share Of Gene Therapy Market 2020 Report Including COVID-19 Impact Analysis And Forecast Till 2026 - Northwest Trail - May 14th, 2020
- Fulcrum Therapeutics, Inc. (FULC) Q1 2020 Earnings Call Transcript - Motley Fool - May 14th, 2020
- Covid 19 Pandemic: Parkinsons disease treatment Market Size, Share & Trends Analysis Report By Product, By Technology, By Application, By End Use,... - May 12th, 2020
- Hofseth Biocare ASA: Two-year research collaboration contract signed with Stanford on the use of Salmon Protein Hydrolysate peptides for the treatment... - May 12th, 2020
- Edited Transcript of FLXN earnings conference call or presentation 7-May-20 8:30pm GMT - Yahoo Finance - May 9th, 2020
- The medicine of music: Tim Vallillee turns to song as therapy for cystic fibrosis and for life - TheChronicleHerald.ca - May 9th, 2020
- Edited Transcript of CLVS earnings conference call or presentation 5-May-20 8:30pm GMT - Yahoo Finance - May 7th, 2020
- Edited Transcript of BMRN earnings conference call or presentation 29-Apr-20 8:15pm GMT - Yahoo Finance - May 1st, 2020
- Immunotherapy Before Surgery Could Advance Care of an Aggressive Form of Skin Cancer - Newswise - April 29th, 2020
- Study provides new insight into the neural circuitry underlying irritability and anxiety in youths - PsyPost - April 24th, 2020
- Cell Harvesting Market Industry Trends and Forecast to 2025 | PerkinElmer Inc, Bertin, Tomtec, Terumo BCT, HynoDent AG, Avita Medical - Bandera County... - April 9th, 2020
- Muscular Dystrophy Association Announces Formation of Strategic Medical Advisory Team of Experts in Neuromuscular Care and Research - BioSpace - April 3rd, 2020
- Retinal Dystrophy Treatment Market Overview,Outlook,Recent Trend by 2026|Novartis AG, GlaxoSmithKline, Applied Genetic Technologies Corporation -... - March 26th, 2020
- iCAD Launches New Initiatives Leveraging Unique Capabilities of its Robust Product Portfolio to Reduce Health Care System Pressures During the... - March 26th, 2020
- Why soap can kill coronavirus and how its discovery changed human history - The Irish Times - March 24th, 2020
- Contract Development and Manufacturing Organization Market worth USD 278.98 Billion by 2026; Increasing Demand for Pharmaceutical Products Will Aid... - March 24th, 2020
- Coronavirus weekend update: Plans outlined to prepare hospitals for surge in patients - Mountain View Voice - March 24th, 2020
- Edited Transcript of SRPT earnings conference call or presentation 26-Feb-20 9:30pm GMT - Yahoo Finance - March 21st, 2020
- A history of soap: How it began and how it fights coronavirus - The Independent - March 20th, 2020
- Edited Transcript of FLXN earnings conference call or presentation 12-Mar-20 8:30pm GMT - Yahoo Finance - March 17th, 2020
- Why soap works - even on coronavirus - and how its discovery altered human history - Chattanooga Times Free Press - March 16th, 2020
- Why Soap Works - The New York Times - March 14th, 2020
- Flexion Therapeutics Inc (FLXN) Q4 2019 Earnings Call Transcript - Motley Fool - March 14th, 2020
- Scarborough brother and sister, aged 11 and 12, with the genetic cholesterol condition FH are helped by new clinic - The Scarborough News - March 14th, 2020
- Spinal Muscular Atrophy Treatment Market to Exhibit a Spectacular CAGR of 28.9%; Growing Initiatives by Government Authorities for Pre-Diagnosis to... - March 7th, 2020
- Study maps landmarks of peripheral artery disease to guide treatment development - University of Illinois News - March 5th, 2020
- Misophonia: A Neurologic, Psychologic, and Audiologic... : The Hearing Journal - LWW Journals - March 5th, 2020
- Precision medicine in 2020: what barriers remain for drug developers? - pharmaceutical-technology.com - March 4th, 2020
- Hemophilia Treatment Market outlook with industry review and forecasts - Technology Magazine - March 4th, 2020
- Precision Cancer Therapies Market Size, Status and Forecast 2025 Trends, Size, Drivers, Strategies, Products and - News Times - March 4th, 2020
- Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets - GlobeNewswire - February 27th, 2020
- Global Genetic Testing Services Market is Expected to Reach USD 67.1 Billion by 2025 : Fior Markets - Yahoo Finance - February 26th, 2020
- When Treating Women With Ovarian Cancer, Gynecologic Oncologist Emphasizes Openness And Dedication Throughout Journey - Forbes - February 24th, 2020
- Lung-MAP: A five-year recap on the first master protocol trial in cancer research - The Cancer Letter - February 22nd, 2020
- Global Cell and Gene Therapy Consumables Market Revenue Expected to Reach USD 6999 Million By 2027 - Northwest Trail - February 21st, 2020
- In Vitro Fertilization Market will Reach USD 36.39 Billion by 2026: Increasing Cases of Infertility Among Men to Positively Influence Growth, says... - February 20th, 2020
- Global Veterinary X-ray Market is Expected to Reach USD 1,167.47 Million by 2025 : Fior Markets - GlobeNewswire - February 20th, 2020
- Parkinsons Disease Treatment Market 2019- Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Instant... - February 15th, 2020
- Cancer Biological Therapy Market Top Key Players, Size, Global Share, Trend, Segmentation, Demand, Opportunities And Forecasts To 2025 - Chronicle 99 - February 15th, 2020
- Outlook on the Gene Therapy for CNS Disorders Market to 2025 by Application, - News by aeresearch - February 1st, 2020
- Cancer Biological Therapy Market Size, Share, Technology, Included Features, Cost, Revenue, Manufacturers, Region, Applications and Forecast to 2025 -... - January 31st, 2020
- Global Age Related Macular Degeneration (AMD) Market: Industry Analysis and Forecast (2019-2026) - Expedition 99 - January 31st, 2020
- UAB: 50 years of Improving Birmingham, Alabama and the World - Birmingham Times - January 31st, 2020
- Parkinsons Disease Treatment Market 2020 Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Science... - January 31st, 2020
- What can hold back the hands of time? Scientists have looked at these five treatments - Ottawa Citizen - January 31st, 2020
- Global Cell Therapy Technologies Market : Industry Analysis and Forecast (2018-2026) - Bulletin 99 - January 25th, 2020
- MDA Awards Venture Philanthropy Funding of More Than $1M to AavantiBio to Develop Gene-Targeting Therapy for Friedreich's Ataxia - P&T Community - January 14th, 2020
- Oncocyte Announces the Commercial Availability of DetermaRx, the First Test for Chemotherapy Benefit Prediction in Patients with Early Stage Non-Small... - January 14th, 2020
- The Region's Health Leaders on What's New and What the Next Decade Will Bring - Business West - January 9th, 2020
- Endothelial Dysfunction Industry 2019-2025 Market Analysis by Size, Share, Growth, Regional, Manufactures, Application and Forecast Research Report -... - January 9th, 2020
- Cell Harvesting Market is Expected to Reach USD 387.9 Million by 2025| Bertin, Tomtec, Terumo BCT, HynoDent AG, Avita Medical, Argos Technologies -... - January 9th, 2020
- Insights on precision oncology developments in Japan and beyond - MobiHealthNews - January 6th, 2020
- Novel discovery in gene therapy to treat kidney diseases - WeForNews - January 5th, 2020
- Top Providers of the Alpha Thalassemia Market gives a New Dimension easing Measurement and Quantification - GuruFocus.com - December 27th, 2019
- This was the best health news over the last decade - USA TODAY - December 18th, 2019
- US Network of Specialized Angelman Clinics to Double Thanks to New Partnership - Angelman Syndrome News - December 13th, 2019
- ICMR issues guidelines for gene therapy in India - Daily Pioneer - December 13th, 2019
- Mergers and Acquisitions Will Strengthen Payer Identity in 2020 - HealthPayerIntelligence.com - December 13th, 2019
- University of Iowa researchers say $18 million grant could soon lead to cure for rare brain disease - KCRG - December 13th, 2019
- Parkinsons Disease Treatment Market 2019- Global Industry Analysis, by Key Players, Segmentation, Application, Demand and Forecast by 2025 - Tribunal... - December 13th, 2019
- Cancer gene therapy backed by Blackstone gets trial win - BioPharma Dive - December 6th, 2019
- Counterculture 73: Summer Jam, Timothy Leary and the Sexual Revolution - Rolling Stone - December 6th, 2019
- Precision Cancer Therapies Market Size, Status and Forecast 2025 Trends, Size, Drivers, Strategies, Products and - The Market Stats News - December 6th, 2019
- World AIDS Day 2019: 37.9M people worldwide were living with HIV at the end of 2018 - USA TODAY - December 2nd, 2019
- Global Parkinsons Disease Treatment Market 2019 Analysis by Industry Growth, Size, Share, Trends and Forecast by 2025 - Eastlake Times - November 30th, 2019
- Diabetic foot wounds kill millions, but high-tech solutions and teamwork are making a difference - Thehour.com - November 28th, 2019
- Macular Degeneration Treatment Market and its Future Outlook and Trend During the Period of 2019 2026 - The Chicago Sentinel - November 25th, 2019
- Edited Transcript of BLFS earnings conference call or presentation 12-Nov-19 9:30pm GMT - Yahoo Finance - November 20th, 2019
- U.S. stem cell clinic offering unapproved therapies brings direct-to-consumer marketing to Ottawa - Ottawa Citizen - November 18th, 2019
- Hemophilia Treatment Market Dynamics, Pin-Point Analysis, Comprehensive Landscape, Demand Key Factors, Market Segments Regions, Therapy For Hemophilia... - November 18th, 2019
- Abuse in cell banking services a global problem - Bioprocess Insider - BioProcess Insider - November 14th, 2019
- Anti-Aging Products and Therapies Market Outlook: Investors Still Miss the Big Assessment - The Market Journal - November 11th, 2019
- Tip Sheet: A clever way to make an AIDS vaccine; how a common cancer mutation actually drives cancer; and a new process that regulates red blood cell... - November 9th, 2019